Medicinal Products


Generic drug of the therapeutic class: Dermatology
active ingredients: Betamethasone
laboratory: Glaxosmithkline

Emulsion for cutaneous application
Dropper bottle of 15 g
All forms


Corticosensitive dermatoses of the scalp:

· Psoriasis,

· seborrheic dermatitis,

· Lichenification.

Note: Each dermatosis must be treated with a corticosteroid of the most appropriate level knowing that depending on the results we may be led to substitute a product of a stronger or less strong activity on all or part of the lesions.

This emulsion form is intended for the lesions of the hairy regions and the scalp.

Dosage BETNEVAL LOTION 0.1% Emulsion for cutaneous application Dropping bottle of 15 g

Treatment should be limited to 1 to 2 applications per day.

An increase in the number of daily applications could aggravate the adverse effects without improving the therapeutic effects.

The lotion must be applied line by line, in small quantities, directly on the scalp. Wash hands after application

Some dermatoses make it desirable to stop gradually. It can be obtained by reducing the frequency of applications and / or by the use of a less strong corticosteroid: or less dosed.

Against indications

· Hypersensitivity to any of the components of the preparation.

· Primitive bacterial, viral, fungal or parasitic infections.

· Ulcerated lesions.

· Application on the eyelids (risk of glaucoma).

Betneval Lotion Side Effects

The side effects listed below have been observed in trials. They are classified by organ class and frequency. Frequencies are defined: very common (≥1 / 10), frequent (≥ 1/100 and <1/10), uncommon (≥ 1/1000 and <1/100), rare (≥1 / 10 000 and <1/1000), very rare (<1 / 10, 000).

No effect has been attributed to the effects of spontaneous notifications.

Infections and infestations

Secondary infections

Not known : Secondary infections, especially under occlusive dressing or in folds, have been reported with local corticosteroids.

Immune system disorders

Not known: hypersensitivity: skin reactions including urticaria.

If signs of hypersensitivity occur, treatment should be discontinued immediately.

Endocrine disorders

Not known : possible systemic effects (see Warnings and precautions for use ).

Skin and subcutaneous tissue disorders

Common : Local burning sensation and pruritus.

Frequency not known : Prolonged use of corticosteroids with strong activity may result in skin atrophy, stretch marks (particularly at the roots of the limbs, and occurring more readily in adolescents), an ecchymotic purpura secondary to atrophy, a fragility of the skin, telangiectasia (to be feared especially on the face).

Acneiform or pustular eruptions, hypertrichosis, depigmentations have been reported.

Allergic contact dermatitis has also been reported with the use of local corticosteroids.

In the face, corticosteroids can create perioral dermatitis or aggravate rosacea (see sections Contraindications and Warnings and precautions for use ).

It may be observed delayed healing of unstressed wounds, pressure ulcers, leg ulcers (see section Contraindications ).

Locally there is a possibility of irritation.

Popular Posts

Category Medicinal Products, Next Article